Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
1803 | 6283 | 36.0 | 76% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
3 | 4 | PLANT SCIENCES//AGRONOMY//FOOD SCIENCE & TECHNOLOGY | 1882812 |
354 | 3 | MICROCYSTIN//HARMFUL ALGAE//MICROCYSTIN LR | 34996 |
1803 | 2 | LANTIBIOTIC//OXAZOLE//DOLASTATIN 10 | 6283 |
8321 | 1 | MARINE CYANOBACTERIA//AERUGINOSIN//LYNGBYA MAJUSCULA | 1267 |
8681 | 1 | LANTIBIOTIC//NISIN//LANTHIONINE | 1228 |
12492 | 1 | OXAZOLE//PHORBOXAZOLE//DIAZONAMIDE A | 902 |
13101 | 1 | 2 IMIDAZOLINE//THIAZOLINE//OXAZOLINE | 860 |
14510 | 1 | DOLASTATIN 10//DIDEMNIN B//CRYPTOPHYCIN | 765 |
20232 | 1 | MICROCIN//LASSO PEPTIDES//MICROCIN J25 | 470 |
20833 | 1 | THIOPEPTIDES//NOSIHEPTIDE//NOCATHIACIN | 444 |
27461 | 1 | METOMINOSTROBIN//ABURAHI S//MELITHIAZOL | 229 |
33929 | 1 | TUBULYSIN//PYRROLO 1 5 BENZOXAZEPINES//PBOX | 118 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | LANTIBIOTIC | authKW | 828602 | 3% | 81% | 211 |
2 | OXAZOLE | authKW | 206099 | 2% | 31% | 139 |
3 | DOLASTATIN 10 | authKW | 147780 | 1% | 89% | 34 |
4 | DIDEMNIN B | authKW | 127671 | 0% | 91% | 29 |
5 | CRYPTOPHYCIN | authKW | 112012 | 0% | 82% | 28 |
6 | DOLASTATIN | authKW | 112012 | 0% | 82% | 28 |
7 | TUBULYSIN | authKW | 109462 | 0% | 87% | 26 |
8 | TZT 1027 | authKW | 109462 | 0% | 87% | 26 |
9 | MICROCIN | authKW | 99795 | 1% | 62% | 33 |
10 | LASSO PEPTIDES | authKW | 98838 | 0% | 88% | 23 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Chemistry, Organic | 30716 | 32% | 0% | 2017 |
2 | Chemistry, Medicinal | 9826 | 12% | 0% | 772 |
3 | Microbiology | 7499 | 16% | 0% | 975 |
4 | Pharmacology & Pharmacy | 2673 | 14% | 0% | 899 |
5 | Biotechnology & Applied Microbiology | 2313 | 9% | 0% | 595 |
6 | Chemistry, Multidisciplinary | 1991 | 14% | 0% | 892 |
7 | Biochemistry & Molecular Biology | 927 | 15% | 0% | 913 |
8 | Plant Sciences | 673 | 6% | 0% | 386 |
9 | Oncology | 98 | 4% | 0% | 274 |
10 | Immunology | 46 | 3% | 0% | 209 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | ABURAHI S | 58299 | 1% | 34% | 35 |
2 | MARINE BIOTECHNOL BIOMED | 40671 | 1% | 11% | 74 |
3 | BLIS TECHNOL LTD | 39183 | 0% | 73% | 11 |
4 | SECT INFECT BIOL | 30394 | 0% | 48% | 13 |
5 | BIOQUIM NUTR | 28593 | 0% | 21% | 28 |
6 | SKAGGS PHARM PHARMACEUT SCI | 27303 | 2% | 5% | 108 |
7 | RAYMOND BEVERLY SACKLER CHEM | 26467 | 0% | 32% | 17 |
8 | SECC FISIOL GENET BACTERIANAS | 21635 | 0% | 64% | 7 |
9 | MARINE BIODISCOVERY | 20767 | 0% | 20% | 21 |
10 | FUNCT FOOD DESIGN | 19474 | 0% | 24% | 17 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | JOURNAL OF NATURAL PRODUCTS | 29020 | 4% | 2% | 269 |
2 | JOURNAL OF ANTIBIOTICS | 16649 | 2% | 2% | 152 |
3 | TETRAHEDRON LETTERS | 13704 | 7% | 1% | 463 |
4 | MARINE DRUGS | 11478 | 1% | 4% | 68 |
5 | ORGANIC LETTERS | 7585 | 3% | 1% | 203 |
6 | JOURNAL OF ORGANIC CHEMISTRY | 7262 | 5% | 1% | 284 |
7 | TETRAHEDRON | 7159 | 4% | 1% | 239 |
8 | SYNLETT | 3839 | 2% | 1% | 108 |
9 | NATURAL PRODUCT REPORTS | 3255 | 0% | 2% | 31 |
10 | ACS CHEMICAL BIOLOGY | 3195 | 1% | 2% | 38 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | LANTIBIOTIC | 828602 | 3% | 81% | 211 | Search LANTIBIOTIC | Search LANTIBIOTIC |
2 | OXAZOLE | 206099 | 2% | 31% | 139 | Search OXAZOLE | Search OXAZOLE |
3 | DOLASTATIN 10 | 147780 | 1% | 89% | 34 | Search DOLASTATIN+10 | Search DOLASTATIN+10 |
4 | DIDEMNIN B | 127671 | 0% | 91% | 29 | Search DIDEMNIN+B | Search DIDEMNIN+B |
5 | CRYPTOPHYCIN | 112012 | 0% | 82% | 28 | Search CRYPTOPHYCIN | Search CRYPTOPHYCIN |
6 | DOLASTATIN | 112012 | 0% | 82% | 28 | Search DOLASTATIN | Search DOLASTATIN |
7 | TUBULYSIN | 109462 | 0% | 87% | 26 | Search TUBULYSIN | Search TUBULYSIN |
8 | TZT 1027 | 109462 | 0% | 87% | 26 | Search TZT+1027 | Search TZT+1027 |
9 | MICROCIN | 99795 | 1% | 62% | 33 | Search MICROCIN | Search MICROCIN |
10 | LASSO PEPTIDES | 98838 | 0% | 88% | 23 | Search LASSO+PEPTIDES | Search LASSO+PEPTIDES |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | ARNISON, PG , BIBB, MJ , BIERBAUM, G , BOWERS, AA , BUGNI, TS , BULAJ, G , CAMARERO, JA , CAMPOPIANO, DJ , CHALLIS, GL , CLARDY, J , ET AL (2013) RIBOSOMALLY SYNTHESIZED AND POST-TRANSLATIONALLY MODIFIED PEPTIDE NATURAL PRODUCTS: OVERVIEW AND RECOMMENDATIONS FOR A UNIVERSAL NOMENCLATURE.NATURAL PRODUCT REPORTS. VOL. 30. ISSUE 1. P. 108-160 | 229 | 54% | 157 |
2 | CHATTERJEE, C , PAUL, M , XIE, LL , VAN DER DONK, WA , (2005) BIOSYNTHESIS AND MODE OF ACTION OF LANTIBIOTICS.CHEMICAL REVIEWS. VOL. 105. ISSUE 2. P. 633-683 | 257 | 63% | 399 |
3 | BIERBAUM, G , SAHL, HG , (2009) LANTIBIOTICS: MODE OF ACTION, BIOSYNTHESIS AND BIOENGINEERING.CURRENT PHARMACEUTICAL BIOTECHNOLOGY. VOL. 10. ISSUE 1. P. 2-18 | 176 | 81% | 200 |
4 | YEH, VSC , (2004) RECENT ADVANCES IN THE TOTAL SYNTHESES OF OXAZOLE-CONTAINING NATURAL PRODUCTS.TETRAHEDRON. VOL. 60. ISSUE 52. P. 11995-12042 | 239 | 73% | 193 |
5 | KNERR, PJ , VAN DER DONK, WA , (2012) DISCOVERY, BIOSYNTHESIS, AND ENGINEERING OF LANTIPEPTIDES.ANNUAL REVIEW OF BIOCHEMISTRY, VOL 81. VOL. 81. ISSUE . P. 479-505 | 140 | 90% | 94 |
6 | CHLIPALA, GE , MO, SY , ORJALA, J , (2011) CHEMODIVERSITY IN FRESHWATER AND TERRESTRIAL CYANOBACTERIA - A SOURCE FOR DRUG DISCOVERY.CURRENT DRUG TARGETS. VOL. 12. ISSUE 11. P. 1654-1673 | 166 | 74% | 26 |
7 | JUST-BARINGO, X , ALBERICIO, F , ALVAREZ, M , (2014) THIOPEPTIDE ANTIBIOTICS: RETROSPECTIVE AND RECENT ADVANCES.MARINE DRUGS. VOL. 12. ISSUE 1. P. 317 -351 | 118 | 79% | 33 |
8 | YANG, X , VAN DER DONK, WA , (2013) RIBOSOMALLY SYNTHESIZED AND POST-TRANSLATIONALLY MODIFIED PEPTIDE NATURAL PRODUCTS: NEW INSIGHTS INTO THE ROLE OF LEADER AND CORE PEPTIDES DURING BIOSYNTHESIS.CHEMISTRY-A EUROPEAN JOURNAL. VOL. 19. ISSUE 24. P. 7662-7677 | 129 | 85% | 17 |
9 | ORTEGA, MA , VAN DER DONK, WA , (2016) NEW INSIGHTS INTO THE BIOSYNTHETIC LOGIC OF RIBOSOMALLY SYNTHESIZED AND POST-TRANSLATIONALLY MODIFIED PEPTIDE NATURAL PRODUCTS.CELL CHEMICAL BIOLOGY. VOL. 23. ISSUE 1. P. 31 -44 | 83 | 73% | 14 |
10 | DUFOUR, A , HINDRE, T , HARAS, D , LE PENNEC, JP , (2007) THE BIOLOGY OF LANTIBIOTICS FROM THE LACTICIN 481 GROUP IS COMING OF AGE.FEMS MICROBIOLOGY REVIEWS. VOL. 31. ISSUE 2. P. 134-167 | 166 | 70% | 61 |
Classes with closest relation at Level 2 |